Search research articles
Contact Us
Filters
Showing results (51-60 of 183) with videos related to
Page
of 19
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 15, 2019
Development and validation of an UPLC-MS/MS method for the therapeutic drug monitoring of oral anti-hormonal drugs in oncology
M van Nuland, N Venekamp, N de Vries, et al.
Biomedical Chromatography : BMC
|
May 16, 2013
Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures
K D Mooiman, R F Maas-Bakker, H Rosing, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 21, 1999
Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC)
H Rosing, W W ten Bokkel Huinink, R van Gijn, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 24, 2017
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of Dexamphetamine in human plasma
M Herbrink, B Thijssen, M J X Hillebrand, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 6, 2011
Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry
S F Teunissen, N G L Jager, H Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 3, 2018
Ultra-sensitive LC-MS/MS method for the quantification of gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma for a microdose clinical trial
M van Nuland, M J X Hillebrand, H Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 30, 2016
Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples
A E Kip, K C Kiers, H Rosing, et al.
Investigational New Drugs
|
September 1, 2005
Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer
J H Beumer, J M Rademaker-Lakhai, H Rosing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 17, 2010
Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma, urine, bile, intestinal contents, faeces and eight selected tissues from mice
S F Teunissen, M L H Vlaming, H Rosing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 30, 2016
Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry
C M Nijenhuis, L Lucas, H Rosing, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 183) with videos related to
Sort By:
Page
of 19
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 15, 2019
Development and validation of an UPLC-MS/MS method for the therapeutic drug monitoring of oral anti-hormonal drugs in oncology
M van Nuland, N Venekamp, N de Vries, et al.
Biomedical Chromatography : BMC
|
May 16, 2013
Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures
K D Mooiman, R F Maas-Bakker, H Rosing, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 21, 1999
Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC)
H Rosing, W W ten Bokkel Huinink, R van Gijn, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 24, 2017
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of Dexamphetamine in human plasma
M Herbrink, B Thijssen, M J X Hillebrand, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 6, 2011
Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry
S F Teunissen, N G L Jager, H Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 3, 2018
Ultra-sensitive LC-MS/MS method for the quantification of gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma for a microdose clinical trial
M van Nuland, M J X Hillebrand, H Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 30, 2016
Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples
A E Kip, K C Kiers, H Rosing, et al.
Investigational New Drugs
|
September 1, 2005
Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer
J H Beumer, J M Rademaker-Lakhai, H Rosing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 17, 2010
Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma, urine, bile, intestinal contents, faeces and eight selected tissues from mice
S F Teunissen, M L H Vlaming, H Rosing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 30, 2016
Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry
C M Nijenhuis, L Lucas, H Rosing, et al.
Page
of 19